|
US5869282A
(en)
*
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
|
US6004924A
(en)
|
1991-12-11 |
1999-12-21 |
Imperial Cancer Research Technology, Ltd. |
Protein sequences of serrate gene products
|
|
US20050112121A1
(en)
*
|
1992-04-30 |
2005-05-26 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
ATE442373T1
(de)
*
|
1995-06-28 |
2009-09-15 |
Imp Cancer Res Tech |
Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
|
|
US20050158859A1
(en)
*
|
1995-09-29 |
2005-07-21 |
Yale University |
Manipulation of non-terminally differentiated cells using the Notch pathway
|
|
US5780300A
(en)
*
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
US6337387B1
(en)
*
|
1995-11-17 |
2002-01-08 |
Asahi Kasei Kabushiki Kaisha |
Differentiation-suppressive polypeptide
|
|
US6291210B1
(en)
*
|
1996-07-16 |
2001-09-18 |
Asahi Kasei Kabushiki Kaisha |
Differentiation inhibitor
|
|
AU773479B2
(en)
*
|
1996-11-07 |
2004-05-27 |
Lorantis Limited |
Notch
|
|
GB9623236D0
(en)
*
|
1996-11-07 |
1997-01-08 |
Imperial College |
Notch
|
|
US6887475B1
(en)
|
1996-11-07 |
2005-05-03 |
Lorantis Limited |
Notch
|
|
WO1998020142A1
(en)
*
|
1996-11-07 |
1998-05-14 |
Lorantis Limited |
Notch
|
|
EP1004669B1
(en)
|
1997-05-14 |
2007-04-18 |
Asahi Kasei Kabushiki Kaisha |
Novel differentiation inhibitor
|
|
US6136952A
(en)
|
1997-06-25 |
2000-10-24 |
University Of Washington |
Human jagged polypeptide, encoding nucleic acids and methods of use
|
|
US6436650B1
(en)
|
1997-07-23 |
2002-08-20 |
Yale University |
Activated forms of notch and methods based thereon
|
|
US6692919B1
(en)
*
|
1997-07-23 |
2004-02-17 |
Yale University |
Activated forms of notch and methods based thereon
|
|
AU1054900A
(en)
*
|
1998-10-30 |
2000-05-22 |
Smith & Nephew Plc |
Compositions comprising notch receptor manipulating agents
|
|
US8084258B2
(en)
*
|
1999-07-12 |
2011-12-27 |
University Of Basel |
Manipulation of tissue of organ type using the notch pathway
|
|
GB9927328D0
(en)
|
1999-11-18 |
2000-01-12 |
Lorantis Ltd |
Immunotherapy
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US20050089518A1
(en)
*
|
2001-12-07 |
2005-04-28 |
Clarke Michael F. |
Prospective identification and characterization of breast cancer stem cells
|
|
AU2001288628A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Loyola University Chicago |
Method and reagents for treatment of skin disorders by modulating the notch pathway
|
|
AU2001297693A1
(en)
*
|
2000-12-08 |
2002-09-12 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
|
EP1410018A1
(en)
*
|
2001-07-25 |
2004-04-21 |
Lorantis Limited |
Method for detecting modultators of notch signalling
|
|
GB0118155D0
(en)
|
2001-07-25 |
2001-09-19 |
Lorantis Ltd |
Superantigen
|
|
US20030185829A1
(en)
*
|
2002-03-12 |
2003-10-02 |
Erich Koller |
Jagged 2 inhibitors for inducing apoptosis
|
|
US20040102401A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of jagged 1 expression
|
|
GB0300428D0
(en)
*
|
2003-01-09 |
2003-02-05 |
Lorantis Ltd |
Medical treatment
|
|
GB0307472D0
(en)
*
|
2003-04-01 |
2003-05-07 |
Lorantis Ltd |
Medical treatment
|
|
EP2003196A3
(en)
*
|
2003-06-09 |
2009-01-07 |
The Regents of the University of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2005074633A2
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
WO2006138275A2
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
PT2500360E
(pt)
|
2005-10-31 |
2015-10-15 |
Oncomed Pharm Inc |
Composições e métodos para diagnóstico e tratamento do cancro
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
US7723112B2
(en)
*
|
2005-10-31 |
2010-05-25 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
WO2008092002A2
(en)
*
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
WO2008140826A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
ES2663536T3
(es)
|
2008-09-26 |
2018-04-13 |
Oncomed Pharmaceuticals, Inc. |
Agentes que se unen a receptores frizzled y usos de los mismos
|
|
US8945569B2
(en)
|
2009-11-19 |
2015-02-03 |
Oncomed Pharmaceuticals, Inc. |
Jagged-binding agents and uses thereof
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
WO2011127472A1
(en)
|
2010-04-09 |
2011-10-13 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for providing hematopoietic function
|
|
JP6165627B2
(ja)
|
2010-04-09 |
2017-07-19 |
フレッド ハッチンソン キャンサー リサーチ センター |
Hlaの適合なしに造血機能を提供するための組成物および方法
|
|
US9834755B2
(en)
|
2011-12-08 |
2017-12-05 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
WO2013192550A2
(en)
|
2012-06-22 |
2013-12-27 |
Cytomx Therapeutics, Inc. |
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
|
|
HK1212216A1
(en)
|
2012-10-23 |
2016-06-10 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
|
EP2943566A1
(en)
|
2013-01-08 |
2015-11-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for expansion of embryonic hematopoietic stem cells
|
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路インヒビターによる処置の方法およびモニタリング
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
NZ758715A
(en)
|
2013-10-31 |
2023-01-27 |
Seattle Children’S Hospital Dba Seattle Children’S Res Institute |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
JP6734283B2
(ja)
|
2015-01-21 |
2020-08-05 |
フレッド ハッチンソン キャンサー リサーチ センター |
遺伝子治療用ポイントオブケア及び/又はポータブルプラットフォーム
|
|
WO2016176652A2
(en)
|
2015-04-29 |
2016-11-03 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
US20180355318A1
(en)
|
2015-04-29 |
2018-12-13 |
Fred Hutchinson Cancer Research Center |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
JP2018537472A
(ja)
|
2015-12-04 |
2018-12-20 |
フレッド ハッチンソン キャンサー リサーチ センター |
増殖造血幹細胞/前駆細胞集団の利用
|
|
WO2020037326A1
(en)
|
2018-08-17 |
2020-02-20 |
Frequency Therapeutics, Inc. |
Compositions and methods for generating hair cells by downregulating foxo
|
|
CA3109647A1
(en)
*
|
2018-08-17 |
2020-02-20 |
Frequency Therapeutics, Inc. |
Compositions and methods for generating hair cells by upregulating jag-1
|
|
CN112680471B
(zh)
*
|
2019-10-17 |
2023-08-01 |
华南农业大学 |
ZmSPL基因在调控玉米柱头乳突细胞发育中的应用
|